Consists of Ambroxol, Loratadine
|
||
Toraxan Pregnancy |
||
Consists of Ambroxol, Loratadine
Category of the fetus by FDA - C.
Ambroxol (Toraxan) Lark Laboratories is contraindicated in threatened miscarriage in I and II trimesters of pregnancy, premature detachment of the placenta, bleeding, or toxicosis in the III trimester of pregnancy. If necessary, the use of salbutamol during pregnancy should be related to the expected benefits of treatment for the mother and the potential risk to the fetus. Currently is insufficient data on the safety of salbutamol in early pregnancy. salbutamol is excreted in breast milk, so if you need to use during lactation should also assess the potential benefits of treatment for the mother and the potential risk to the child.
Loratadine (Toraxan) has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy. Loratadine (Toraxan) is only recommended for use during pregnancy when benefit outweighs risk.
See references
Loratadine (Toraxan) concentrations in human milk approximate that found in the serum of the mother. Approximately 0.029% of the administered dose was excreted in human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
See references
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|